CAMLAW: Complementary and Alternative Medicine Law Blog

Peanut butter alert by FDA

The federal food and drug administration (FDA) has put out an alert on certain brands of peanut butter.

The FDA is warning people not to eat certain jars of Peter Pan or Great Value peanut butter.
The peanut butter may be contaminated with salmonella, bacteria that cause food poisoning.
Suspect jars bear a number on the lid beginning with the digits "2111." Any peanut butter carrying that number -- and bought since May 2006 -- should be discarded immediately.
All the peanut butter included in the warning was made at a ConAgra plant in Sylvester, Ga.
Since some Great Value brand peanut butter is not made by ConAgra, those jars are not affected by the warning.
Symptoms of salmonella food poisoning include fever, diarrhea, and abdominal cramps.
Salmonella can cause life-threatening infections in people in poor health or with weakened immune systems.
Call a doctor right away if you get any of the above symptoms after eating Peter Pan or Great Value brand peanut butter with the 2111 product code.
Doctors should report any illnesses to state or local health authorities.
The FDA warning is based on a CDC study linking 288 cases of food poisoning in 39 states to different types of Peter Pan peanut butter. The FDA says it learned of the study Feb. 13.
This salmonella outbreak is considered to be ongoing.
ConAgra will stop making food products at its Sylvester plant until FDA investigators determine the exact cause of the contamination.
"Although none of our extensive product tests have indicated the presence of salmonella, we are taking this precautionary measure because consumer health and safety is our top priority," ConAgra spokesman Chris Kircher says, in a news release.
"We are working closely with the FDA to better understand its concerns, and we will take whatever additional measures are needed to ensure the safety, quality, and wholesomeness of our products," Kircher notes.
The FDA will issue updates as more information becomes available.
Consumers who have questions should contact ConAgra's toll-free hotline at 866-344-6970.
Law Offices of Michael H. Cohen offers general corporate legal services, litigation consultation, and expertise in health law with a unique focus on alternative, complementary, and integrative medical therapies.

Michael H. Cohen is Principal in Law Offices of Michael H. Cohen and also President of the Institute for Integrative and Energy Medicine (also known as the Institute for Health, Ethics, Law, Policy & Society), a forum for exploration of legal, regulatory, ethical, and health policy issues involved in the judicious integration of complementary and alternative medical therapies (such as acupuncture and traditional oriental medicine, chiropractic, massage therapy, herbal medicine) and conventional clinical care. The most recent published book by Michael H. Cohen on health care law, regulation, ethics and policy pertaining to complementary, alternative and integrative medicine and related fields is Healing at the Borderland of Medicine and Religion. This is the fourth book in a series, following Complementary and Alternative Medicine: Legal Boundaries and Regulatory Perspectives (1998), Beyond Complementary Medicine: Legal and Ethical Perspectives on Health Care and Human Evolution (2000), and Future Medicine: Ethical Dilemmas, Regulatory Challenges, and Therapeutic Pathways to Health Care and Healing in Human Transformation (2003).

Health care and corporate lawyer Michael H. Cohen has also been admitted to the Bar of England and Wales as a Solicitor (non-practicing), adding to Bar membership in four U.S. states.

Trackbacks (0) Links to blogs that reference this article Trackback URL
Comments (0) Read through and enter the discussion with the form at the end

Michael H. Cohen, Esq.; 468 North Camden Dr. | Beverly Hills, California 90210 | 310-844-3173